within Pharmacolibrary.Drugs.ATC.A;

model A10AF01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 5.9999999999999995e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 8.999999999999999e-05,
    k12             = 0.6,
    k21             = 0.6
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10AF01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Insulin (human) is a peptide hormone used for the treatment of diabetes mellitus, both type 1 and type 2. It lowers blood glucose by facilitating cellular glucose uptake and is an essential hormone therapy in insulin-dependent diabetes. Approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for subcutaneous administration in healthy adult volunteers. Values represent averages from published literature.</p><h4>References</h4><ol><li><p>Nishimura, E, et al., &amp; Haahr, H (2021). Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing. <i>BMJ open diabetes research &amp; care</i> 9(1) –. DOI:<a href=&quot;https://doi.org/10.1136/bmjdrc-2021-002301&quot;>10.1136/bmjdrc-2021-002301</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34413118/&quot;>https://pubmed.ncbi.nlm.nih.gov/34413118</a></p></li><li><p>Ma, X, et al., &amp; Leishman, D (2022). Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements. <i>Journal of diabetes science and technology</i> 16(2) 401–407. DOI:<a href=&quot;https://doi.org/10.1177/1932296820972719&quot;>10.1177/1932296820972719</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33242998/&quot;>https://pubmed.ncbi.nlm.nih.gov/33242998</a></p></li><li><p>Brogden, RN, &amp; Heel, RC (1987). Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. <i>Drugs</i> 34(3) 350–371. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198734030-00003&quot;>10.2165/00003495-198734030-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3315622/&quot;>https://pubmed.ncbi.nlm.nih.gov/3315622</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10AF01;
